Photo: Carolyn Kaster/AP
President Trump issued Executive Order #13876 today, establishing a roadmap toward transparency in the American healthcare system. See the EO, along with video of the news conference below.
Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First
Issued on: June 24, 2019
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered as follows:
Section 1. Purpose. My Administration seeks to enhance the ability of patients to choose the healthcare that is best for them. To make fully informed decisions about their healthcare, patients must know the price and quality of a good or service in advance. With the predominant role that third-party payers and Government programs play in the American healthcare system, however, patients often lack both access to useful price and quality information and the incentives to find low-cost, high-quality care. Opaque pricing structures may benefit powerful special interest groups, such as large hospital systems and insurance companies, but they generally leave patients and taxpayers worse off than would a more transparent system.
#1 It is one of several conditions, known as fetal alcohol spectrum disorders, which results from alcohol exposure during the mother’s pregnancy.
#2 Individuals with FAS may have problems with their hearing, memory, vision, attention span, and capabilities to communicate and learn. This can happen due to the fact that alcohol in the mother’s blood passes to her developing fetus through the placenta.
#3 The amount of alcohol ingested during pregnancy to cause the syndrome is still unknown, however, women should completely avoid alcoholic beverages during pregnancy.
COMMITTEE SENSITIVE
1
EXECUTIVE SESSION COMMITTEE ON THE JUDICIARY JOINT W/ COMMITTEE ON GOVERNMENT REFORM AND OVERSIGHT, U.S. HOUSE OF REPRESENTATIVES WASHINGTON, D.C.
INTERVIEW OF: JAMES RYBICKI
Thursday, January 18, 2018 Washington, D.C. (240 pages)
The interview in the above matter was held in Room 2141, Rayburn House Office Building, commencing at 10:15 a.m.
COMMITTEE SENSITIVE
1
EXECUTIVE SESSION COMMITTEE ON THE JUDICIARY JOINT W/ COMMITTEE ON GOVERNMENT REFORM AND OVERSIGHT, U.S. HOUSE OF REPRESENTATIVES WASHINGTON, D.C.
INTERVIEW OF: ANDREW McCABE
Thursday, December 21, 2017 Washington, D.C.
The interview in the above matter was held in Room 2141, Rayburn House Office Building, commencing at 10:54 a.m. (251 pages)
EXECUTIVE SESSION COMMITTEE ON THE JUDICIARY, JOINT WITH THE COMMITTEE ON OVERSIGHT AND GOVERNMENT REFORM, U.S. HOUSE OF REPRESENTATIVES, WASHINGTON, D.C.
INTERVIEW OF: LORETTA LYNCH
Wednesday, December 19, 2018
Washington, D.C.
The interview in the above matter was held in Room 2141, Rayburn House Office Building, commencing at 10:17 a.m. (191 pps)
Members Present: Representatives Goodlatte, Issa, Jordan, Biggs, Nadler, Cummings, Jackson Lee, Cohen, Raskin, Demings, Krishnamoorthi, and Connolly.
1
Chairman Goodlatte. We'll go on the record. This is a transcribed interview of Loretta Lynch.
Chairman Gowdy and I requested this interview as part of a joint investigation by the House Committee on the Judiciary and the House Committee on Oversight and Government Reform into decisions made and not made by the Department of Justice and the Federal Bureau of Investigation regarding the 2016 Presidential election.
Would the witness please state her name for the record?
Ms. Lynch. Good morning, Mr. Chairman. Loretta Lynch. ChairmanGoodlatte. Iwanttothankyouforappearingtoday,and
we appreciate your willingness to appear voluntarily.
My name is Bob Goodlatte, chairman of the Judiciary Committee. I will now ask everyone else who is here in the room, other than
End of content
End of content